Evidence map›Paper›PMID 27742828›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Cytokine-Induced Glucocorticoid Resistance from Eosinophil Activation: Protein Phosphatase 5 Modulation of Glucocorticoid Receptor Phosphorylation and Signaling.

Konrad Pazdrak, Christof Straub, Rosario Maroto, Susan Stafford, Wendy I White, William J Calhoun, Alexander Kurosky

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Mechanisms of glucocorticoid resistance in hypereosinophilic syndromes.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2019
    Trial
  2. Article
  3. Article
  4. Article
  5. IL-8 promotes pyroptosis through ERK pathway and mediates glucocorticoid resistance in chronic rhinosinusitis with nasal polyps.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. [Liver failure and glucocorticoid resistance].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2020
    Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Konrad PazdrakDepartment of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX 77555.ORCID 0000-0002-2771-5132
Christof StraubDepartment of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX 77555.
Rosario MarotoDepartment of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX 77555.
Susan StaffordDepartment of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX 77555.ORCID 0000-0002-5648-6981
Wendy I WhiteMedImmune LLC, Gaithersburg, MD 20878; and.
William J CalhounDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, The University of Texas Medical Branch, Galveston, TX 77555.ORCID 0000-0001-7075-712X
Alexander KuroskyDepartment of Biochemistry and Molecular Biology, The University of Texas Medical Branch, Galveston, TX 77555; akurosky@utmb.edu.ORCID 0000-0002-2889-2317
National Heart Lung and Blood Institute · USThe University of Texas Medical Branch at Galveston · US

Funding

Synthetic Organic Chemistry CoreP30ES006676 · NIEHS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI ELFERINK, CORNELIS JOHAN · 1995 to 2017
$21.7M
UTMB Clinical and Translational Science AwardKL2TR001441 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI AMEREDES, BILL T · 2015 to 2024
$4.0M
UTMB Clinical and Translational Science AwardKL2RR029875 · NCRR · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2009 to 2011
$609k
NHLBI PROTEOMICS INITIATIVE-N01HV28184N01HV028184 · HV · UNIV OF TEXAS MEDICAL BRANCH · PI KUROSKY, ALEXANDER NONE · 2002 to 2006
–
NCATS NIH HHS KL2 TR001441NCRR NIH HHS KL2 RR029875NHLBI NIH HHS HHSN268201000037CNHLBI NIH HHS N01 HV028184NIEHS NIH HHS P30 ES006676
6 · The paper itself

Abstract

The mechanisms contributing to persistent eosinophil activation and poor eosinopenic response to glucocorticoids in severe asthma are poorly defined. We examined the effect of cytokines typically overexpressed in the asthmatic airways on glucocorticoid signaling in in vitro activated eosinophils. An annexin V assay used to measure eosinophil apoptosis showed that cytokine combinations of IL-2 plus IL-4 as well as TNF-α plus IFN-γ, or IL-3, GM-CSF, and IL-5 alone significantly diminished the proapoptotic response to dexamethasone. We found that IL-2 plus IL-4 resulted in impaired phosphorylation and function of the nuclear glucocorticoid receptor (GCR). Proteomic analysis of steroid sensitive and resistant eosinophils identified several differentially expressed proteins, namely protein phosphatase 5 (PP5), formyl peptide receptor 2, and annexin 1. Furthermore, increased phosphatase activity of PP5 correlated with impaired phosphorylation of the GCR. Importantly, suppression of PP5 expression with small interfering RNA restored proper phosphorylation and the proapoptotic function of the GCR. We also examined the effect of lipoxin A4 on PP5 activation by IL-2 plus IL-4. Similar to PP5 small interfering RNA inhibition, pretreatment of eosinophils with lipoxin A4 restored GCR phosphorylation and the proaptoptotic function of GCs. Taken together, our results showed 1) a critical role for PP5 in cytokine-induced resistance to GC-mediated eosinophil death, 2) supported the dependence of GCR phosphorylation on PP5 activity, and 3) revealed that PP5 is a target of the lipoxin A4-induced pathway countering cytokine-induced resistance to GCs in eosinophils.

Indexed as

ApoptosisAsthmaCytokinesDexamethasoneEosinophilsGranulocyte-Macrophage Colony-Stimulating FactorHumansHypersensitivityInterleukin-2Interleukin-3Interleukin-4Interleukin-5LipoxinsMetabolism, Inborn ErrorsNuclear ProteinsPhosphoprotein PhosphatasesCytokinesDexamethasoneGranulocyte-Macrophage Colony-Stimulating FactorIL4 protein, humanInterleukin-2Interleukin-3Interleukin-4Interleukin-5lipoxin A4LipoxinsNuclear ProteinsPhosphoprotein Phosphatasesprotein phosphatase 5Receptors, GlucocorticoidRNA, Small InterferingTumor Necrosis Factor-alpha

Identifiers

PMID27742828
PMCPMC5098561
OpenAlexW2547997552

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.